Notice: file_put_contents(): Write of 8938 bytes failed with errno=28 No space left on device in /var/www/tg-me/post.php on line 50
Readhub | Telegram Webview: readhub_cn/255130 -
Telegram Group & Telegram Channel



tg-me.com/readhub_cn/255130
Create:
Last Update:

万泰生物:2024年净利润1.06亿元 同比下降91.49%

万泰生物2024年营收22.45亿元,同比下降59.25%,净利润1.06亿元,同比下降91.49%,公司拟不进行利润分配。

媒体报道
万泰生物:2024年净利润1.06亿元,同比下降91.49% 钛媒体
万泰生物:2024年净利润1.06亿元 同比下降91.49% 格隆汇/财联社/第一财经
万泰生物:2024年归母净利润1.06亿元,同比下降91.49% 界面

事件追踪
2025-01-16 万泰生物:预计2024年净利润同比减少90%到93%
2024-10-25 万泰生物:前三季度净利润2.67亿元,同比下降85.25%
2024-08-22 万泰生物:2024年上半年归母净利同比下降84.7%
2024-07-10 万泰生物:预计上半年净利同比减少85.90%到82.96%
2024-01-24 万泰生物去年净利预降七成,二价宫颈癌疫苗收入减少约42亿
2023-03-20 万泰生物去年净利增134%,二价宫颈癌疫苗销量超2500万支

#热门话题

BY Readhub


Warning: Undefined variable $i in /var/www/tg-me/post.php on line 283

Share with your friend now:
tg-me.com/readhub_cn/255130

View MORE
Open in Telegram


Readhub Telegram | DID YOU KNOW?

Date: |

That growth environment will include rising inflation and interest rates. Those upward shifts naturally accompany healthy growth periods as the demand for resources, products and services rise. Importantly, the Federal Reserve has laid out the rationale for not interfering with that natural growth transition.It's not exactly a fad, but there is a widespread willingness to pay up for a growth story. Classic fundamental analysis takes a back seat. Even negative earnings are ignored. In fact, positive earnings seem to be a limiting measure, producing the question, "Is that all you've got?" The preference is a vision of untold riches when the exciting story plays out as expected.

However, analysts are positive on the stock now. “We have seen a huge downside movement in the stock due to the central electricity regulatory commission’s (CERC) order that seems to be negative from 2014-15 onwards but we cannot take a linear negative view on the stock and further downside movement on the stock is unlikely. Currently stock is underpriced. Investors can bet on it for a longer horizon," said Vivek Gupta, director research at CapitalVia Global Research.

Readhub from us


Telegram Readhub
FROM USA